Did you miss GVK BIO’s recent webinar on Targeted protein degradation in inflammation and cancer therapy. You can access the following by filling this quick form:
This webinar will focus on our efforts with PROTACs in the areas of inflammation and cancer. Specifically, speakers has discussed challenges and opportunities for developing PROTACs in the areas of autoimmune and inflammatory diseases driven by IL-1R/TLR1 signaling and inflammasome activation and in potentially undruggable epigenetic pathways that involve bromodomain proteins, histone acetyltransferases and deacetylases.
During this session, participants will learn:
Duration – 1hour
Featured Speakers
